Insider Stock Trading History of Levine Evan


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Levine Evan since year 2005. The trader's CIK number is 1199838. At the time of this reporting, Levine Evan is the Chief Executive Officer of Nef Enterprises, Inc. . (stock ticker symbol NEFT). See this page for all insider trading activities at Nef Enterprises, Inc. .

Note that in the past LEVINE EVAN also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Levine Evan since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2016-11-08 PBYA Nef Enterprises, Inc. Buy 4,928,046 .80 3,942,436
2008-02-04 ANX Adventrx Pharmaceuticals Inc Buy 5,000 .42 2,100
2004-10-04 ANX Adventrx Pharmaceuticals Inc Buy 3,000 1.19 3,570
2006-05-05 ANX Adventrx Pharmaceuticals Inc Buy 1,000 4.47 4,470
2006-05-01 ANX Adventrx Pharmaceuticals Inc Buy 1,000 5.15 5,150
2004-11-30 ANX Adventrx Pharmaceuticals Inc Buy 1,800 .86 1,548
2006-05-18 ANX Adventrx Pharmaceuticals Inc Buy 1,000 4.36 4,360
2006-01-06 ANX Adventrx Pharmaceuticals Inc Buy 2,000 3.86 7,726
2006-06-19 ANX Adventrx Pharmaceuticals Inc Buy 1,000 3.15 3,150
2006-11-13 ANX Adventrx Pharmaceuticals Inc Buy 1,000 2.63 2,630
2008-02-05 ANX Adventrx Pharmaceuticals Inc Buy 5,000 .42 2,125
2004-10-26 ANX Adventrx Pharmaceuticals Inc Buy 3,200 .93 2,976
2008-02-08 ANX Adventrx Pharmaceuticals Inc Buy 5,000 .51 2,525
2005-03-22 ANX Adventrx Pharmaceuticals Inc Sale 3,000 1.50 4,500
2005-10-27 ANX Adventrx Pharmaceuticals Inc Sale 3,800 3.16 12,008
2007-10-22 ANX Adventrx Pharmaceuticals Inc Sale 1,000 .60 601
2006-07-24 ANX Adventrx Pharmaceuticals Inc Sale 1,000 2.82 2,820
2007-11-19 ANX Adventrx Pharmaceuticals Inc Sale 3,000 .59 1,770
2006-02-23 ANX Adventrx Pharmaceuticals Inc Sale 2,000 4.29 8,580
2006-01-03 ANX Adventrx Pharmaceuticals Inc Sale 1,200 3.22 3,864
2007-12-14 ANX Adventrx Pharmaceuticals Inc Buy 60,000 .46 27,600
2007-02-06 QTXB Quantrx Biomedical Corp Sale 993,009 .70 695,106
2005-09-14 ANX Adventrx Pharmaceuticals Inc Sale 54,399 3.59 195,510

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Levine Evan (Chief Executive Officer of Nef Enterprises, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.